US7413734B2 - Treatment of retinitis pigmentosa with human umbilical cord cells - Google
Patents US7413734B2 - Treatment of retinitis pigmentosa with human umbilical cord cells …

The present invention provides compositions and methods of using embryonic-like stem
cells that originate from a post-partum placenta with conventional cord blood compo sitions …

5,589,376 A 12/1996 Anderson et a1......... 435/240.2 5,670,483 A* 9/1997 zhang et
31'""""""""" 514/14 Cells derivedfromhumanumbilical cords are disclosedalong 5,677,181 A …

A method of manufacturing a tissue matrix for implantation into a patient is disclosed. The
method sets forth collecting embryonic stem cells from a placenta which has been treated to …

The present invention provides a biomaterial comprising a mammalian umbilical cord
membrane. The biomaterial can additionally comprise Wharton's jelly and/or one or more …

Cells derived from postpartum placenta and methods for their isolation are provided by the
invention. The invention further provides cultures and compositions of the placenta-derived …

US7524489B2 - Regeneration and repair of neural tissue using postpartum-derived cells -
Google Patents US7524489B2 - Regeneration and repair of neural tissue using postpartum-derived …

The present invention provides placental stem cells and pla cental stem cell populations,
and methods of culturing, pro liferating and expanding the same. The invention also pro …

5,811,094. A 9/1998 Caplanet al...... 424/93.7 tum tissue-derived cells, are provided by the
invention. The 5,827,735 A 10/1998 Young et al................. 435/325 invention also provides …

5,639,618 A 6/1997 Gay 5,843,780 A 12/1998 Thomson 5,919,702 A* 7/1999 Purchio et
al............... 435/378 5,993,387 A 11/1999 Moore et al. 6,087,113 A 7/2000 Caplanet al …